Value Proposition

Naproxen More Cost-Effective Than Generic Celecoxib for Patients with Knee Osteoarthritis and Moderate-to-High Levels of Pain
“This analysis provides a framework for providers and payers evaluating the cost-effectiveness of generic celecoxib given a range of discontinuation rates, toxicity rates, and drug costs,” said Elena Losina, PhD, and colleagues. Read More ›

New Recommendations May Increase Out-of-Pocket RA Treatment Costs for Medicare Part D Recipients

Dr Doshi and colleagues used the study sample to predict what costs would have been using the MedPAC proposals and found that for patients using specialty RA drugs, the OOP costs would remain front loaded into the beginning of the year, ranging from $512 to $1076 per month from January to May.

Read More ›

Subscribe to
Rheumatology Practice Management

Stay up to date with rheumatology news & updates by subscribing to receive the free RPM print publications or weekly e‑Newsletter.

I'd like to receive: